What is the dosage for Cefaclor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefaclor Dosage

The standard dosage of cefaclor for adults is 250 mg every 8 hours, which can be doubled to 500 mg every 8 hours for more severe infections or less susceptible organisms. 1

Adult Dosing

  • Standard dose: 250 mg orally every 8 hours 1
  • Severe infections (e.g., pneumonia) or less susceptible organisms: 500 mg orally every 8 hours 1
  • Cefaclor may be administered without dose adjustment in patients with impaired renal function 1

Pediatric Dosing

  • Standard dose: 20 mg/kg/day divided every 8 hours 1
  • More serious infections, otitis media, or less susceptible organisms: 40 mg/kg/day divided every 8 hours (maximum 1 g/day) 1
  • Alternative twice-daily regimen for otitis media and pharyngitis: Total daily dose divided every 12 hours 1

Pediatric Weight-Based Dosing Examples:

  • 9 kg child (20 mg/kg/day): 2.5 mL (125 mg/5 mL suspension) three times daily 1
  • 18 kg child (20 mg/kg/day): 5 mL (125 mg/5 mL suspension) three times daily 1
  • 9 kg child (40 mg/kg/day): 5 mL (125 mg/5 mL suspension) three times daily 1
  • 18 kg child (40 mg/kg/day): 5 mL (250 mg/5 mL suspension) three times daily 1

Treatment Duration

  • β-hemolytic streptococcal infections: Minimum 10 days of therapy 1
  • Most other infections: 3-5 days after resolution of signs and symptoms 2

Critical Clinical Considerations

Cefaclor has significant limitations that restrict its use in modern practice. The 2004 Otolaryngology guidelines explicitly state that cefaclor has poor activity against H. influenzae, fair activity against penicillin-susceptible pneumococci, and no activity against drug-resistant S. pneumoniae (DRSP), resulting in poor overall efficacy against bacterial respiratory tract pathogens 3.

The 2005 sinusitis guidelines further note that cefaclor has inadequate activity against all β-lactamase-producing M. catarrhalis and some H. influenzae, plus a high prevalence of serum sickness-like reactions, making it an unattractive treatment option 3.

Common Pitfalls to Avoid:

  • Do not use cefaclor as first-line therapy for respiratory infections given its poor coverage of common pathogens 3
  • The pediatric dose of 20 mg/kg/day may be inadequate for otitis media; consider 40 mg/kg/day 4
  • Food delays absorption; administer on an empty stomach when possible 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of cefaclor.

American journal of hospital pharmacy, 1981

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.